Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Vor Biopharma Vor Bio to Participate in the Stifel 2024 Healthcare Conference November 12, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update November 07, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer September 30, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies September 05, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio to Participate in Upcoming Investor Conferences August 28, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update August 08, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) August 02, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) July 09, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) June 04, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update May 09, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio to Participate in Upcoming Investor Conferences May 06, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) May 03, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors May 02, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio to Participate in Upcoming Investor Conferences April 01, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update March 20, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) March 05, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio to Participate in Upcoming Investor Conferences March 04, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference February 07, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) February 02, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update January 17, 2024 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) December 21, 2023 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) December 01, 2023 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit November 27, 2023 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference November 09, 2023 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update November 07, 2023 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) November 03, 2023 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio to Participate in Upcoming Investor Conferences November 03, 2023 From Vor Biopharma Via GlobeNewswire Tickers VOR Multiple Clinical and Preclinical Presentations at ASH 2023 Highlight Vor Bio’s Novel eHSC and CAR-T Platform November 02, 2023 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) October 03, 2023 From Vor Biopharma Via GlobeNewswire Tickers VOR Vor Bio to Participate in Upcoming Investor Conferences September 25, 2023 From Vor Biopharma Via GlobeNewswire Tickers VOR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
